Page last updated: 2024-08-21

chenodeoxycholic acid and Cholangitis

chenodeoxycholic acid has been researched along with Cholangitis in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	12 (27.91)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	25 (58.14)	24.3611
2020's	6 (13.95)	2.80

Authors

Authors	Studies
Díaz-González, Á; Londoño, MC	1
Buchanan-Peart, KA; Levy, C	1
Gulamhusein, AF; Hansen, BE	1
Hirschfield, G; Invernizzi, P; Liberman, A; MacConell, L; Malecha, ES; Parés, A; Shiffman, M; Vargas, V	1
Gershwin, ME; Hirschfield, GM; Lleo, A; Wang, GQ	1
Dyson, JK; Jones, DEJ; Wetten, A	1
Davidson, BR; Eusebi, LH; Gurusamy, KS; Saffioti, F; Thorburn, D; Tsochatzis, E	1
Jones, DE; Mells, GF	1
Hegade, VS; Jones, DEJ; Wong, LL	1
Choi, G; Jimenez, M; Rahal, H; Saab, S; Suraweera, D; Viramontes, M	1
Alvaro, D; Canonico, PL; Carbone, M; Craxi, A; Floreani, A; Gardini, I; Gasbarrini, A; Invernizzi, P; Kruger, P; Lanati, E; Marzioni, M; Mennini, FS; Muratori, L; Ronco, V; Vespasiani Gentilucci, U	1
Edwards, JE; Eliot, L; Karan, S; MacConell, L; Parkinson, A	1
Lindor, KD; Silveira, MG	1
Bernuzzi, F; Carbone, M; Gershwin, ME; Invernizzi, P; Malinverno, F; Mousa, HS; Ronca, V	1
Anaya, JM; Gershwin, ME; Lleo, A; Marzorati, S	1
Levy, C	1
Al Ani, M; Nadir, A; Quigley, G	1
Aschenbrenner, DS	1
Bossen, L; Grønbæk, H; Hamberg, O; Jepsen, P; Ott, P; Ytting, H	1
Alexander, GJM; Chapman, MH; Collier, J; Dyson, JK; Hirschfield, GM; Hübscher, S; Jones, DEJ; Patanwala, I; Pereira, SP; Thain, C; Thorburn, D; Tiniakos, D; Walmsley, M; Webster, G	1
Christ, MM	1
Aguilera, L; Albillos, A; Martínez, J	1
Andreone, P; Bowlus, CL; Drenth, JPH; Hirschfield, GM; MacConell, L; Malecha, ES; Nevens, F; Pencek, R; Shapiro, D; Shiffman, ML; Trauner, M; Vargas, V	1
Ali, AH; Lindor, KD	1
Bowlus, CL; Kenney, JT; Navarro, R; Rice, G	1
Erlinger, S	1
Banken, R; Chapman, R; Chhatwal, J; Corey, K; Hur, C; Klebanoff, M; Loos, AM; Ollendorf, DA; Pratt, DS; Samur, S	1
Gerken, G; Nitschmann, S	1
Parés, A	1
Li, B; Ma, X; Wang, QX	1
Sherlock, S	1
Egberts, EH; Schomerus, H	1
Schentke, KU	1
Faust, H; Gyr, K	1
Paumgartner, G; Weber, M	1
Bouchier, IA	1
Coyne, MJ; Schoenfield, LJ	1
Bloomer, JR; Boyer, JL	1
Bouchier, IA; Cullen, J; James, O	1
Malè, PJ; Meyer, P	1
George, P	1

Reviews

17 review(s) available for chenodeoxycholic acid and Cholangitis

Article	Year
Novel Therapies in Primary Biliary Cholangitis: What Is in the Pipeline? Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Chenodeoxycholic Acid; Cholangitis; Humans; Liver Cirrhosis, Biliary; Quality of Life; Ursodeoxycholic Acid	2022
Primary biliary cholangitis. Lancet (London, England), 2020, 12-12, Volume: 396, Issue:10266 Topics: Autoimmune Diseases; Biomarkers; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Fatigue; Humans; Pruritus; Risk Factors; Ursodeoxycholic Acid	2020
Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. The Cochrane database of systematic reviews, 2017, 03-28, Volume: 3 Topics: Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Chronic Disease; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mitochondria; Network Meta-Analysis; Penicillamine; Quality of Life; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2017
What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis? Digestive diseases (Basel, Switzerland), 2017, Volume: 35, Issue:4 Topics: Chenodeoxycholic Acid; Cholangitis; Disease Progression; Humans; Liver Cirrhosis, Biliary; Quality of Life; Ursodeoxycholic Acid	2017
Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:12 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Colchicine; Fibric Acids; Humans; Immunosuppressive Agents; Silymarin; Treatment Failure; Ursodeoxycholic Acid	2017
Investigational drugs in phase II clinical trials for primary biliary cholangitis. Expert opinion on investigational drugs, 2017, Volume: 26, Issue:10 Topics: Animals; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Disease Progression; Drug Design; Drugs, Investigational; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2017
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis. Expert review of clinical immunology, 2017, Volume: 13, Issue:12 Topics: Autoimmunity; Bile Ducts, Intrahepatic; Chenodeoxycholic Acid; Cholangitis; Fibrosis; Humans; Immunotherapy; Liver; Liver Cirrhosis, Biliary; Molecular Targeted Therapy; Ursodeoxycholic Acid; Ustekinumab	2017
Primary biliary cholangitis: a comprehensive overview. Hepatology international, 2017, Volume: 11, Issue:6 Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Biopsy; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Fibric Acids; Humans; Immunosuppressive Agents; Liver; Prognosis; Ursodeoxycholic Acid	2017
[New name and new treatments for primary biliary cholangitits]. Ugeskrift for laeger, 2018, Mar-05, Volume: 180, Issue:10 Topics: Anti-Inflammatory Agents; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2018
Risk stratification and treatment of primary biliary cholangitis. Revista espanola de enfermedades digestivas, 2019, Volume: 111, Issue:1 Topics: Adult; Age Factors; Alkaline Phosphatase; Biomarkers; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; Disease Progression; Fibric Acids; Glucocorticoids; Humans; Liver Cirrhosis; Liver Transplantation; Middle Aged; Risk Assessment; Risk Factors; Sex Factors; Treatment Failure; Ursodeoxycholic Acid	2019
Obeticholic acid for the treatment of primary biliary cholangitis. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:13 Topics: Animals; Autoimmune Diseases; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; End Stage Liver Disease; Genome-Wide Association Study; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2016
Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update. Journal of managed care & specialty pharmacy, 2016, Volume: 22, Issue:10-a-s Sup Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Congresses as Topic; Disease Progression; Drug Resistance; Drug Therapy, Combination; Education, Pharmacy, Continuing; End Stage Liver Disease; Evidence-Based Medicine; Formularies as Topic; Humans; Insurance Coverage; Insurance, Pharmaceutical Services; Liver Transplantation; Middle Aged; Prescription Fees; Rare Diseases; Receptors, Cytoplasmic and Nuclear; Satellite Communications; Ursodeoxycholic Acid	2016
Novel Treatment Strategies for Primary Biliary Cholangitis. Seminars in liver disease, 2017, Volume: 37, Issue:1 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Disease Progression; Fibric Acids; Gastrointestinal Agents; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2017
[Research advances in autoimmune liver diseases in 2016]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2017, Feb-20, Volume: 25, Issue:2 Topics: Autoimmune Diseases; Biomedical Research; Chenodeoxycholic Acid; Cholangitis; Cholangitis, Sclerosing; Clinical Trials, Phase III as Topic; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Diseases	2017
Update on gallstones. Progress in clinical and biological research, 1984, Volume: 152 Topics: Adult; Aged; Bile Duct Diseases; Chenodeoxycholic Acid; Cholangitis; Cholelithiasis; Drainage; Female; Gallstones; Humans; Male; Middle Aged; Pregnancy; Recurrence	1984
[Caroli syndrome: the focal dilatation of intrahepatic bile ducts]. Ergebnisse der inneren Medizin und Kinderheilkunde, 1981, Volume: 46 Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Amyloidosis; Bile; Bile Duct Diseases; Bile Ducts, Intrahepatic; Biliary Dyskinesia; Chenodeoxycholic Acid; Child; Child, Preschool; Cholangiography; Cholangitis; Cholelithiasis; Female; Humans; Infant; Kidney; Kidney Diseases, Cystic; Liver; Liver Cirrhosis; Male; Middle Aged; Syndrome	1981
Disorders of the extrahepatic bile ducts. Clinics in gastroenterology, 1973, Volume: 2, Issue:1 Topics: Ampulla of Vater; Anti-Bacterial Agents; Bile Duct Neoplasms; Bile Ducts; Biliary Tract Diseases; Chenodeoxycholic Acid; Cholangiography; Cholangitis; Cholecystectomy; Cholelithiasis; Cholestasis; Common Bile Duct; Cysts; Duodenal Neoplasms; Gallstones; Humans; Iatrogenic Disease	1973

Trials

2 trial(s) available for chenodeoxycholic acid and Cholangitis

Article	Year
Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver, 2020, Volume: 40, Issue:5 Topics: Bilirubin; Chenodeoxycholic Acid; Cholangitis; Humans; Liver Cirrhosis, Biliary; Liver Function Tests	2020
Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study. The lancet. Gastroenterology & hepatology, 2019, Volume: 4, Issue:6 Topics: Alkaline Phosphatase; Bilirubin; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Dose-Response Relationship, Drug; Double-Blind Method; Fatigue; Female; Gastrointestinal Agents; Humans; Male; Middle Aged; Pruritus; Ursodeoxycholic Acid	2019

Article

Year

Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis.

Liver international : official journal of the International Association for the Study of the Liver, 2020, Volume: 40, Issue:5

Topics: Bilirubin; Chenodeoxycholic Acid; Cholangitis; Humans; Liver Cirrhosis, Biliary; Liver Function Tests

2020

Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study.

The lancet. Gastroenterology & hepatology, 2019, Volume: 4, Issue:6

Topics: Alkaline Phosphatase; Bilirubin; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Dose-Response Relationship, Drug; Double-Blind Method; Fatigue; Female; Gastrointestinal Agents; Humans; Male; Middle Aged; Pruritus; Ursodeoxycholic Acid

2019

Other Studies

24 other study(ies) available for chenodeoxycholic acid and Cholangitis

Article	Year
Predicting liver-related serious adverse events in patients with primary biliary cholangitis-related cirrhosis treated with obeticholic acid. Liver international : official journal of the International Association for the Study of the Liver, 2022, Volume: 42, Issue:11 Topics: Chenodeoxycholic Acid; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Beyond Biochemical Responses, Use of Histologic Staging to Predict Outcomes of Patients With Primary Biliary Cholangitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020, Volume: 18, Issue:5 Topics: Chenodeoxycholic Acid; Cholangitis; Humans; Liver Cirrhosis, Biliary	2020
Specific considerations for the management of primary biliary cholangitis: are the drug treatment options good enough? Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:15 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Pharmaceutical Preparations; Ursodeoxycholic Acid	2021
Obeticholic acid (Ocaliva) for primary biliary cholangitis. The Medical letter on drugs and therapeutics, 2017, 03-27, Volume: 59, Issue:1517 Topics: Chenodeoxycholic Acid; Cholangitis; Gastrointestinal Agents; Humans; Liver; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Treatment Outcome	2017
Stratified medicine and primary biliary cholangitis. The lancet. Gastroenterology & hepatology, 2017, Volume: 2, Issue:5 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Drug Therapy, Combination; Humans; Treatment Outcome; Ursodeoxycholic Acid	2017
Primary Biliary Cholangitis: advances in management and treatment of the disease. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2017, Volume: 49, Issue:8 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; Disease Progression; Drug Therapy, Combination; End Stage Liver Disease; Humans; Ursodeoxycholic Acid	2017
Assessment of Pharmacokinetic Interactions Between Obeticholic Acid and Caffeine, Midazolam, Warfarin, Dextromethorphan, Omeprazole, Rosuvastatin, and Digoxin in Phase 1 Studies in Healthy Subjects. Advances in therapy, 2017, Volume: 34, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Caffeine; Chenodeoxycholic Acid; Cholangitis; Cytochrome P-450 Enzyme System; Dextromethorphan; Digoxin; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Midazolam; Middle Aged; Omeprazole; Rosuvastatin Calcium; Warfarin	2017
Evolving role of obeticholic acid in primary biliary cholangitis. Hepatology (Baltimore, Md.), 2018, Volume: 67, Issue:5 Topics: Chenodeoxycholic Acid; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2018
Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation. Digestive diseases and sciences, 2018, Volume: 63, Issue:2 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Drug Administration Schedule; Female; Humans; Jaundice; Middle Aged; Ursodeoxycholic Acid	2018
Excessive Dosing of Obeticholic Acid May Increase Risk of Liver Damage. The American journal of nursing, 2018, Volume: 118, Issue:2 Topics: Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholangitis; Dose-Response Relationship, Drug; Gastrointestinal Agents; Humans; United States; United States Food and Drug Administration	2018
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut, 2018, Volume: 67, Issue:9 Topics: Alanine Transaminase; Alkaline Phosphatase; Autoantibodies; Bilirubin; Biomarkers; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Disease Progression; Gastroenterology; Humans; Liver Cirrhosis, Biliary; Mitochondria; Predictive Value of Tests; Risk Assessment; Risk Factors; Sensitivity and Specificity; Societies, Medical; Treatment Outcome; United Kingdom; Ursodeoxycholic Acid	2018
[In process]. Medizinische Monatsschrift fur Pharmazeuten, 2017, Volume: 40, Issue:3 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Humans; Ursodeoxycholic Acid	2017
Obeticholic acid in primary biliary cholangitis. Clinics and research in hepatology and gastroenterology, 2017, Volume: 41, Issue:1 Topics: Chenodeoxycholic Acid; Cholangitis; Double-Blind Method; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2017
Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis. Hepatology (Baltimore, Md.), 2017, Volume: 65, Issue:3 Topics: Adult; Biopsy, Needle; Chenodeoxycholic Acid; Cholangitis; Cohort Studies; Cost-Benefit Analysis; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Prospective Studies; Quality-Adjusted Life Years; Risk Assessment; Severity of Illness Index; Time; Treatment Outcome	2017
[Obeticholic acid in primary biliary cholangitis : PBC OCA international study of efficacy (POISE)]. Der Internist, 2017, Volume: 58, Issue:2 Topics: Chenodeoxycholic Acid; Cholangitis; Humans	2017
[Clinical and internal medicine therapy of biliary tract diseases]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1980, Aug-15, Volume: 35, Issue:16 Topics: Ampulla of Vater; Biliary Tract Diseases; Chenodeoxycholic Acid; Cholangiography; Cholangitis; Cholecystitis; Cholelithiasis; Diagnosis, Differential; Humans; Ursodeoxycholic Acid	1980
[Important problem in practice: disorders of bile secretion (proceedings)]. MMW, Munchener medizinische Wochenschrift, 1979, May-25, Volume: 121, Issue:21 Topics: Biliary Tract; Chenodeoxycholic Acid; Cholangitis; Cholecystitis; Cholelithiasis; Cholestasis; Humans; Radiography	1979
[New therapeutic possibilities in the diagnosis of congenital cystic bile duct dilatations (author's transl)]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1977, Volume: 126, Issue:3 Topics: Bile Ducts; Biliary Dyskinesia; Biliary Tract Diseases; Chenodeoxycholic Acid; Cholangiography; Cholangitis; Cysts; Diagnosis, Differential; Dilatation, Pathologic; Drainage; Female; Humans; Liver Cirrhosis; Liver Diseases; Syndrome	1977
[Surgical, endoscopical and medical treatment of gallstones (author's transl)]. Therapeutische Umschau. Revue therapeutique, 1978, Volume: 35, Issue:9 Topics: Calcium; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholangitis; Cholecystectomy; Cholecystitis; Cholelithiasis; Cholestasis; Cholesterol; Deoxycholic Acid; Humans	1978
Diseases of the alimentary system. Gall stones. British medical journal, 1976, Oct-09, Volume: 2, Issue:6040 Topics: Aged; Anti-Bacterial Agents; Chenodeoxycholic Acid; Cholangitis; Cholecystectomy; Cholecystitis; Cholelithiasis; Diet; Gallstones; Humans; Middle Aged; Time Factors	1976
Gallstone disease. Postgraduate medicine, 1975, Volume: 57, Issue:1 Topics: Adolescent; Adult; Bile; Bile Pigments; Biliary Fistula; Chenodeoxycholic Acid; Child; Cholangiography; Cholangitis; Cholecystectomy; Cholecystitis; Cholelithiasis; Cholesterol; Edema; Female; Gallbladder Neoplasms; Gallstones; Humans; Intestinal Obstruction; Male; Middle Aged; Pancreatitis; Sex Factors	1975
Phenobarbital effects in cholestatic liver diseases. Annals of internal medicine, 1975, Volume: 82, Issue:3 Topics: Adult; Bile Ducts, Intrahepatic; Bilirubin; Chenodeoxycholic Acid; Child; Child, Preschool; Cholangitis; Cholestasis; Cholic Acids; Feces; Female; Hepatitis; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Phenobarbital; Pruritus; Rose Bengal; Sulfobromophthalein	1975
Chenodeoxycholic acid therapy for gallstones: effectiveness, toxicity and influence on bile acid metabolism. The Quarterly journal of medicine, 1975, Volume: 44, Issue:174 Topics: Adult; Aged; Bile; Bile Acids and Salts; Biopsy; Chenodeoxycholic Acid; Cholangitis; Cholelithiasis; Cholesterol; Female; Humans; Lipids; Lipoproteins; Lithocholic Acid; Liver; Liver Function Tests; Male; Middle Aged; Radiography	1975
[Choice and modalities of the treatment of biliary lithiasis]. Schweizerische medizinische Wochenschrift, 1986, Aug-05, Volume: 116, Issue:31-32 Topics: Age Factors; Aged; Chenodeoxycholic Acid; Cholangitis; Cholecystectomy; Cholelithiasis; Endoscopy; Female; Humans; Male; Middle Aged; Pancreatitis; Risk; Ursodeoxycholic Acid	1986